Vesiculobullous skin disease
MONDO:0006617Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990)
Also known as: vesiculobullous skin disease, Sneddon Wilkinson disease, Sneddon-Wilkinson disease, skin diseases, vesicular, subcorneal pustular dermatoses, subcorneal pustular dermatosis, bullous dermatoses, bullous skin disease
216 clinical trials for this condition and its sub-types, 3 tagged with Vesiculobullous skin disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Vesiculobullous skin disease
-
Herpes zoster 73 trials
3 sub-types
- Geniculate herpes zoster 0 trials
- Ophthalmic herpes zoster 0 trials
- Zoster sine herpete 0 trials
-
Autoimmune bullous skin disease 7 trials · 56 incl. sub-types
11 sub-types
- Pemphigus 20 trials · 28 incl. sub-types Sub-types →
- Bullous pemphigoid 18 trials
- Mucous membrane pemphigoid 5 trials · 9 incl. sub-types Sub-types →
- Acquired epidermolysis bullosa 3 trials
- Dermatitis herpetiformis 1 trial Sub-types →
- Pemphigoid 1 trial
- IgA pemphigus 0 trials
- Anti-p200 pemphigoid 0 trials
- Linear IgA Dermatosis 0 trials
- Paraneoplastic pemphigus 0 trials
- Subcorneal pustular dermatosis 0 trials
-
Epidermolysis bullosa 24 trials · 46 incl. sub-types
2 sub-types
- Inherited epidermolysis bullosa 5 trials · 38 incl. sub-types Sub-types →
- Acquired epidermolysis bullosa 3 trials
-
Cellulitis 29 trials · 31 incl. sub-types
3 sub-types
- Orbital cellulitis 3 trials
- Ludwig's angina 0 trials
- Anaerobic cellulitis 0 trials
-
Chickenpox 26 trials
-
1 sub-type
-
Gas gangrene 0 trials
-
Papular urticaria 0 trials
Most studied deeper sub-types
-
Can mRNA technology outsmart shingles? a new vaccine trial aims to find out
Vaccine Stopped earlyThis trial tests an experimental mRNA vaccine, mRNA-1468, to see if it can safely prevent shingles in healthy adults aged 50 and older. Participants receive either the new vaccine, a placebo, or an existing shingles vaccine (Shingrix) to compare safety and immune response. The st…
Phase 1 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Aug 07, 2026 00:00 UTC
-
MRNA shingles vaccine trial ends early – what we know
Vaccine Stopped earlyThis study tested several experimental mRNA vaccines against shingles in healthy adults aged 50 to 85. The goal was to check safety and immune response compared to the current shingles vaccine, Shingrix. The trial was terminated early, so results are limited, but the data may hel…
Phase 1/2 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
Can an extra shot boost COVID protection in autoimmune patients?
Disease control Stopped earlyThis study tests whether an additional dose of a COVID-19 vaccine can improve immune protection in adults and children with autoimmune diseases like rheumatoid arthritis, lupus, multiple sclerosis, and others who are taking immunosuppressive medications. Participants who had a we…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug shows promise for blistering skin disease in extended trial
Disease control Stopped earlyThis study looks at the long-term safety of a drug called efgartigimod for adults with moderate-to-severe bullous pemphigoid, a condition that causes painful blisters. Participants who finished the main study can continue treatment for up to 48 weeks, with the option to pause and…
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC